CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

CVRx, Inc.NASDAQ: CVRX

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 26.36M shares rose 1.9% year over year, behind the +12.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.9% toward the trailing-twelve-month pace of +12.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
26.36M+0.5% QoQ
Last fiscal yearDec 2025
26.08M+15.4% YoY
LTMMar 2026
26.2M+12.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.9%——
1 year+15.4%——
3-year CAGR+8.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
26.08M USD
Year-over-year change
+15.4%
4-year CAGR
+5.9%

Weighted Avg Shares vs competitors

How CVRX compares with its peers on the latest reported figures

  • CVRX's LTM Mar 2026 weighted avg shares of 26.2M shares is the 9th highest of the 10 companies compared; the peer median is 44.68M shares.
  • Its year-over-year change of +12.8% is the 5th highest of 10, against a peer median of +10.5%.
  • Over three fiscal years its annual growth of +8.3% compares with a peer median of +4.9%.
CVRX Competitors Peer median
Weighted Avg Shares for CVRX and competitors
Company Period LTM YoY 3-year CAGR
CERSCerus CorporationLTM Mar 2026192.35M +3.7%+2.6%
PRQRProQR Therapeutics N.V.LTM Mar 2026104.77M +19.6%+13.7%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
SENSSenseonics Holdings, Inc.LTM Mar 202640.57M +23.7%+21.3%
VMDViemed Healthcare, Inc.LTM Mar 202638.65M -1.0%+0.2%
MASS908 Devices Inc.LTM Mar 202636.25M +4.5%+4.8%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
SNWVSANUWAVE Health, Inc.LTM Mar 20268.57M +83.3%+80.1%
Peer median (excluding CVRX) 44.68M+10.5%+4.9%

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.04M22.47M39.3M51.29M56.65M
Cost of Revenue3.64M5M6.26M8.33M8.31M
Gross Profit9.4M17.47M33.04M42.96M48.34M
Gross Margin72.1%77.8%84.1%83.8%85.3%
Research & Development7.5M9.95M11.63M11.13M11.13M
Selling, General & Admin27.86M50.05M64.51M91.32M88.47M
Operating Expenses35.36M60M76.14M102.45M99.61M
Depreciation & Amortization168K412K522K619K756K
EBITDA(40.6M)(40.74M)(38.73M)(54.89M)(46.74M)
EBITDA Margin-311.4%-181.3%-98.6%-107.0%-82.5%
Operating Income(25.97M)(42.53M)(43.1M)(59.49M)(51.27M)
Operating Margin-199.2%-189.3%-109.7%-116.0%-90.5%
Interest Income00000
Interest Expense2.22M165K1.8M4.4M5.83M
Other Income / Expenses(17.02M)1.21M2.05M(420K)(2.06M)
Income Before Tax(42.99M)(41.32M)(41.05M)(59.91M)(53.32M)
Pre-Tax Margin-329.8%-183.9%-104.5%-116.8%-94.1%
Income Tax Expense91K109K147K55K(18K)
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Net Margin-330.5%-184.4%-104.8%-116.9%-94.1%
EPS (Basic)(2.11)(2.02)(1.99)(2.65)(2.04)
EPS (Diluted)(2.11)(2.02)(1.99)(2.65)(2.04)
Weighted Avg Shares20.72M20.51M20.7M22.6M26.08M
Weighted Avg Shares (Diluted)20.72M20.53M20.75M22.6M26.08M

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.